Business Context and Reporting Period
This Form 8-K reports on the results of the 2022 Annual Meeting of Stockholders held by MyMD Pharmaceuticals, Inc. on December 14, 2022. The company is incorporated in New Jersey and its common stock trades on The Nasdaq Capital Market under the symbol MYMD.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
At the Annual Meeting, 30,840,727 votes were present in person or by proxy. Two matters were voted upon:
- Election of Directors: All six nominees were elected to one-year terms. Notable voting statistics include:
| Nominee | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Chris Chapman | 19,923,914 | 287,893 | 10,628,920 |
| Craig Eagle | 20,115,061 | 96,746 | 10,628,920 |
| Christopher C. Schreiber | 20,066,262 | 145,545 | 10,628,920 |
| Joshua Silverman | 18,720,289 | 1,491,518 | 10,628,920 |
| Jude Uzonwanne | 17,816,077 | 2,395,730 | 10,628,920 |
| Bill J. White | 20,157,803 | 54,004 | 10,628,920 |
- Ratification of Auditors: The appointment of Morison Cogen LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022, was ratified.
| Category | Votes |
|---|---|
| For | 30,778,525 |
| Against | 40,617 |
| Abstaining | 21,585 |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The report states that no other matters were considered or voted upon at the meeting.
Important Facts for Investors to Verify
- Verify the significant number of broker non-votes (10,628,920) relative to the total votes present, which indicates a large portion of shares were held in street name without voting instructions on the director election.
- Confirm the specific terms of the newly elected directors, which expire at the 2023 annual meeting.
- Review the definitive proxy statement filed on October 26, 2022, for detailed background on the director nominees and auditor ratification.